Technion Research & Development Foundation

About

Portfolio · 10

Mana.bio

AI-based Programmable Drug Delivery

1 round $19.5M committed Latest: 2023-10

Nanose Medical

Frontline Risk Stratification with Breath Biomarkers & Proprietary AI Algorithms

1 round $1.0M committed Latest: 2023-08

Nevia bio

Early Diagnostic Solutions for Gynecological Disease

1 round $3.1M committed Latest: 2023-08

Inhalify

Smart Asthma Inhaler for Children

1 round $18K committed Latest: 2023-07

Envizion Medical

Body Navigation for Enteral Feeding Tube Placement

1 round $18.0M committed Latest: 2020-09

Regulus

AI Counter-Drone Defense System for Military Assets

1 round $4.0M committed Latest: 2020-05

Aleph Farms

Cellular Agriculture Technology

2 rounds $13.3M committed Latest: 2019-05

Metabomed

Target-inhibiting Anticancer Drugs

1 round $18.0M committed Latest: 2016-04

Avraham Pharmaceuticals

Prevention of Neurodegenerative Disorders

3 rounds $14.2M committed Latest: 2016-02

Amplio

Special Education Learning Platform

1 round $1.3M committed

Investment activity

1 portfolio exit on record.

Q&A

What is the primary focus of Technion Research & Development Foundation's investments?

Technion Research & Development Foundation primarily focuses on Health Tech & Life Sciences, with 6 out of 9 portfolio companies in this sector. They also have investments in Education & Knowledge Technologies, Aerospace, Defense & HLS, and Agriculture & Food Technologies.

Can you name some of Technion Research & Development Foundation's notable portfolio companies?

Notable portfolio companies include Aleph Farms, which focuses on Cellular Agriculture Technology, and Mana.bio, an AI-based Programmable Drug Delivery company.

What investment stages does Technion Research & Development Foundation typically engage in?

Technion Research & Development Foundation typically invests in Seed and A Round stages. According to startupim data, they have made 5 Seed investments and 2 A Round investments.

Has Technion Research & Development Foundation had any notable exits?

Yes, Technion Research & Development Foundation had an exit in June 2021 with Envizion Medical, which went public on TASE with a valuation of $45M.

When was Technion Research & Development Foundation founded?

Technion Research & Development Foundation was founded in 1952.

Where is Technion Research & Development Foundation headquartered?

Technion Research & Development Foundation is headquartered in Haifa, Israel.

What is the most recent investment activity by Technion Research & Development Foundation?

Technion Research & Development Foundation has been active recently, with investment rounds recorded in August and October 2023.

Who are some key team members at Technion Research & Development Foundation?

Key team members include Rona Samler, CBO, and Lihi Zelnik-Manor, VP for Innovation & Industry Relations.